The biggest loser was POLY:Polymetal which dropped 19% after a trading update. It didn't look too bad to me, but clearly the market doesn't agree.
IES:Invinity Energy dropped 16% and seems to be heading downwards consistently.
CWR:Ceres Power is my most volatile share, and this week dropped 11% after a rally in the last 2 weeks.
RDT:Rosslyn Data and SAE:Simec Atlantis Energy dropped 11% and 9% but neither are worth anything so it's barely noticeable
EDV:Endeavour Mining has had a miserable few weeks and dropped another 5% to go 32% down.
UKW:Greencoat UK Wind looked like it might break into profit but dropped 5% and is now 14% down.
JLP:Jubilee Metals is sliding relentlessly and dropped another 5% to give some pretty massive losses across the portfolio.
There is precious little good news.
BLU:Blue Star Capital climbed 6% but is worth nothing.
Share of the Week is TRX:Tissue Regenix which climbed 13% after some good results and may actually turn itself around. I'm still down 55% but that's a lot better than before, and I spent £3.5k on my holding, so it is one of my larger commitments.
Here's the ISA and shares portfolio after week 27 of year 9.
| Weekly Change | |||
| Cash | £66.59 | -£76.30 | |
| Portfolio cost | £99,231.92 | +£55.99 | |
| Portfolio sell value (bid price-commission) | £50,905.76 | (-48.7%) | -£1,339.13 |
| Potential profits | £2,333.98 | -£124.72 | |
| Yr 9 Dividends | £202.72 | +£0 | |
| Yr 9 Interest | £3.29 | +£0 | |
| Yr 9 Profit from sales | £11.13 | -£20.31 | |
| Yr 9 proj avg monthly profit | £28.06 | (0.5%) | -£4.46 |
| Total Dividends | £12,114.15 | +£0 | |
| Total Interest | £5.22 | +£0 | |
| Total Profit from sales | £17,309.66 | -£20.31 | |
| Average monthly cash profit | £283.75 | (4.8%) | -£0.85 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Compound performance | 41% | +0% |
I sold some of my magic formula shares so I could put in place my transition to the ISA being for more speculative high risk investments.
I sold my 11 GAW:Games Workshop shares at 9931.6655p making £25.81 (2.9%) profit, or 4% if you include the dividend. I sold my 54 PLUS:Plus 500 shares at 1799.8673p making a £46.11 (4.6%) loss, although only a 1% loss if you include the dividend.
I invested around half of the proceeds in SBTX:SkinBioTherapeutics as I believe the share price has been punished too severely for the acquisition news, and it doesn't change the possibility of strong revenues coming from the Croda deal. I bought 9190 shares at 11.174p costing £1,038.84. The share price has gone up slightly since then but they are 4% down thanks to spread and commission.
I've been watching AFC:AFC Energy for a while. I'm a strong believer in the possibilities of hydrogen, and so I will be targeting ISA purchases in the hydrogen area in the near future. I bought 5,613 shares at 19.0632p costing £1,079.97. They have dropped fractionally since, so I'm down 3% but most of that is spread and commission.
Meanwhile the whole portfolio took a beating and my cheapest OPTI:Optibiotix shares are the only ones in profit, and they dropped 0.5p so potential profits down by £124 and the slight loss on my share sales has results in a drop in performance for year 9.
Still generally looking flat despite the drop this week.
Not far below the trend line, and it probably won't flatten much as we'll be above 12 month ago for almost 6 months if we maintain this level.
Still generally looking flat despite the drop this week.
Not far below the trend line, and it probably won't flatten much as we'll be above 12 month ago for almost 6 months if we maintain this level.
The SIPP looks like this after week 427 overall and week 11 of year 9.
| Weekly Change | ||||
| Cash | £147.82 | +£0 | ||
| Portfolio cost | £104,266.40 | +£0 | ||
| Portfolio sell value (bid price - commission) | £58,291.88 | (-44.1%) | -£1,061.96 | |
| Potential profits | £808.09 | -£182.93 | ||
| Yr 9 Dividends | £86.79 | +£0 | ||
| Yr 9 Interest | £1.10 | +£0 | ||
| Yr 9 Profit from sales | £3,373.97 | +£0 | ||
| Yr 9 proj avg monthly profit | £1,349.33 | (23.4%) | -£134.94 | |
| Total Dividends | £14,721.67 | +£0 | ||
| Total Interest | £7.03 | +£0 | ||
| Total Profit from sales | £14,209.87 | +£0 | ||
| Average monthly cash profit | £281.56 | (4.9%) | -£0.66 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Compound performance | 40% | +0% |
Not much happened. I lost about a third of last week's gains, and potential profit dropped by £182 mainly due to JLP:Jubilee Metals going to loss, but all my profitable shares dropped in value. Fortunately this was mitigated by a 4% rise in PAF:Pan Africa Resources which led to it going £44 into potential profit.
Pretty similar to the ISA
Same story as ISA.
The trading account looks like this after week 393 overall and week 29 of year 8.
I took advantage of my SBTX:SkinBioTherapeutics purchase in the ISA to use my Trading cash to top up SBTX by including them in the purchase so I only had the one lot of commission and so won't reflect it in the cost for this account. I bought 1,263 shares at 11.174p costing £141.12 and so my total holding is 2,003 at an average price of 14.065p costing £281.73 which is a lot closer to my general £500 target. Lets hope I don't have to hold them in here for too long!
| Weekly Change | |||
| Cash | £0.07 | -£141.12 | |
| Portfolio cost | £2,076.23 | +£141.12 | |
| Portfolio sell value (bid price - commission) | £1,226.93 | (-40.9%) | -£22.44 |
| Potential profits | £0 | +£0 | |
| Year 8 Dividends | £8.56 | +£0 | |
| Year 8 Interest | £0 | +£0 | |
| Year 8 Profit | £283.99 | +£0 | |
| Yr 8 proj avg monthly profit | £43.71 | (+25.3%) | -£1.56 |
| Dividends | £68.66 | +£0 | |
| Interest | £0.03 | +£0 | |
| Profit from sales | -£646.70 | +£0 | |
| Average monthly cash profit | -£6.37 | (-3.7%) | +£0.02 |
| (Sold stocks profit + Dividends - Fees / Months) |
I took advantage of my SBTX:SkinBioTherapeutics purchase in the ISA to use my Trading cash to top up SBTX by including them in the purchase so I only had the one lot of commission and so won't reflect it in the cost for this account. I bought 1,263 shares at 11.174p costing £141.12 and so my total holding is 2,003 at an average price of 14.065p costing £281.73 which is a lot closer to my general £500 target. Lets hope I don't have to hold them in here for too long!
Meanwhile a 1% increase in BARC:Barclays wasn't enough to offset the drops in everything else.
Grim, as the green line includes cash, so the cost line has gone up but the green line hasn't.
I think the trend line is going to switch downwards pretty soon. Maybe the week after next.
One good week and 4 bad weeks so far in 2024. Not a very good start, and still no light at the end of any of my tunnels. My portfolio is still worth £31k less than I originally invested, despite having a long term average of £558 profit per month from sales and dividends. It's my current holding that's the problem, with virtually everything showing a heavy loss. My really big holdings are OPTI:Optibiotix, JLP:Jubileee Metals, PBX:Probiotix, SBTX:SkinBioTherapeutics and CAML:Central Asia Metals. They are all doing absolutely rubbish with their share price, despite me being more than happy with the progress the companies are making. All I can do is hang on in there and hope the market recognises the true value of these companies.
Grim, as the green line includes cash, so the cost line has gone up but the green line hasn't.
I think the trend line is going to switch downwards pretty soon. Maybe the week after next.
One good week and 4 bad weeks so far in 2024. Not a very good start, and still no light at the end of any of my tunnels. My portfolio is still worth £31k less than I originally invested, despite having a long term average of £558 profit per month from sales and dividends. It's my current holding that's the problem, with virtually everything showing a heavy loss. My really big holdings are OPTI:Optibiotix, JLP:Jubileee Metals, PBX:Probiotix, SBTX:SkinBioTherapeutics and CAML:Central Asia Metals. They are all doing absolutely rubbish with their share price, despite me being more than happy with the progress the companies are making. All I can do is hang on in there and hope the market recognises the true value of these companies.
No comments:
Post a Comment